Consonance Capital Management LP 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 1:57 pm Sale |
2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Consonance Capital Management LP | 0 0.000% |
-2,729,709 (Position Closed) |
Filing |
| 2021-02-17 2:23 pm Sale |
2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Consonance Capital Management LP | 2,729,709 6.380% |
-3,328,796 (-54.94%) |
Filing |
| 2021-02-16 2:22 pm Purchase |
2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Consonance Capital Management LP | 6,058,505 9.990% |
6,058,505 (New Position) |
Filing |